SCHEMBL7600797

SCHEMBL7600797

CC(C)(C)c1cccc(-c2c3ccccc3c(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)c3ccccc23)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KMT2A Q03164 1/20 0.40
PPARG P37231 5/20 0.39
PPARA Q07869 2/20 0.39
KIF11 P52732 1/20 0.39
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
SERPINE1 P05121 1/20 0.35
OPRD1 P41143 3/20 0.35
PTAFR P25105 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRK1 P41145 1/20 0.34
HDAC4 P56524 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10098586 0.92 KDM4E (0.46) KDM4EATML3MBTL1KMT2APPARG
SCHEMBL261887 0.91 KDM4E (0.44) KDM4EATML3MBTL1KMT2APPARG
SCHEMBL262540 0.91 KDM4E (0.44) KDM4EATML3MBTL1KMT2APPARG
SCHEMBL10098620 0.90 KDM4E (0.45) KDM4EATML3MBTL1KMT2APPARG
SCHEMBL10098606 0.90 KDM4E (0.43) KDM4EATML3MBTL1KMT2APPARG
SCHEMBL12000705 0.90 KIF11 (0.49) KDM4EATML3MBTL1KMT2APPARG
SCHEMBL12853070 0.89 L3MBTL1 (0.44) KDM4EATML3MBTL1KMT2APPARG
SCHEMBL19735293 0.89 RXRA (0.48) KDM4EATML3MBTL1KMT2APPARG
SCHEMBL9890880 0.89 KDM4E (0.44) KDM4EATML3MBTL1KMT2APPARG
SCHEMBL7603786 0.89 KMT2A (0.41) KDM4EATML3MBTL1KMT2APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8845926-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-30 US disclosed
US-8845926-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-30 US disclosed
US-8518492-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-08-27 US disclosed
US-8518492-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-08-27 US disclosed
US-20130005067-A1 Anthracene Derivative, Material For Light Emitting Element, Light Emitting Element, Light Emitting Device, And Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-01-03 US disclosed
US-20120288620-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-11-15 US disclosed
US-8298687-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-30 US disclosed
US-8231942-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-07-31 US disclosed
US-8183793-B2 Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-22 US disclosed
US-8183793-B2 Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-22 US disclosed
US-20120007066-A1 ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-12 US disclosed
US-8039122-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-10-18 US disclosed
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-03 US disclosed
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-03 US disclosed
US-20090317539-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-12-24 US disclosed
US-20090015140-A1 Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-01-15 US disclosed
US-20080286445-A1 COMPOSITION, AND METHOD OF FABRICATING LIGHT-EMITTING ELEMENT SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-20 US disclosed
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-05-08 US disclosed
WO-2008026614-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE ALAD, CYP2C9, CYP1A1 KDM4E 2175/4885ATM 527/4885L3MBTL1 3456/4885
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE ALAD, CYP2C9, CYP1A1 KDM4E 2175/4885ATM 527/4885L3MBTL1 3456/4885
US-20090015140-A1 Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device CRY1, CRY2, CYBA KDM4E 2566/4885ATM 729/4885L3MBTL1 3184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.